Cathodal iontophoresis of treprostinil and iloprost induces a sustained increase in cutaneous flux in rats

British Journal of Pharmacology

Volumn 162, Issue 3, 2011, Pages 557-565

  Blaise, S ^a,b   Roustit, M ^a   Millet, C ^a   Ribuot, C ^a   Boutonnat, J ^c   Cracowski, J L ^a,b  

^a INSERM   (France)

^b GRENOBLE UNIVERSITY HOSPITAL   (France)

^c LABORATOIRE TIMC IMAG   (France)

Author keywords

iloprost; iontophoresis; microcirculation; prostaglandin analogue; prostaglandin I2; rat; treprostinil

Indexed keywords

ILOPROST; PROSTACYCLIN; UNIPROST;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG TOLERABILITY; HINDLIMB; IONTOPHORESIS; LASER DOPPLER FLOWMETRY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SCLERODERMA; SKIN BLOOD FLOW; SKIN CONDUCTANCE; SKIN DEFECT; SKIN ULCER; VASODILATATION;

ADMINISTRATION, CUTANEOUS; ANIMALS; ANTIHYPERTENSIVE AGENTS; ELECTRODES; EPOPROSTENOL; HEMODYNAMICS; HUMANS; ILOPROST; IONTOPHORESIS; MALE; NITROPRUSSIDE; RATS; RATS, WISTAR; SKIN;

EID: 78651458666     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.2010.01045.x     Document Type: Article

References (19)

1. Alexander SP, Mathie A, Peters JA, (2008). Guide to Receptors and Channels (GRAC), 3rd edition. Br J Pharmacol 153 (Suppl. 2): S1-S209.
2. Blaise S, Hellmann M, Roustit M, Isnard S, Cracowski JL, (2010). Oral sildenafil increases skin hyperaemia induced by iontophoresis of sodium nitroprusside in healthy volunteers. Br J Pharmacol 160: 1128-1134.
3. Chung L, Shapiro L, Fiorentino D, Baron M, Shanahan J, Sule S, et al. (2009). MQX-503, a novel formulation of nitroglycerin, improves the severity of Raynaud's phenomenon: a randomized, controlled trial. Arthritis Rheum 60: 870-877.
4. Cracowski JL, Minson CT, Salvat-Melis M, Halliwill JR, (2006). Methodological issues in the assessment of skin microvascular endothelial function in humans. Trends Pharmacol Sci 27: 503-508.
5. Dixit N, Bali V, Baboota S, Ahuja A, Ali J, (2007). Iontophoresis-an approach for controlled drug delivery: a review. Curr Drug Deliv 4: 1-10.
6. Durand S, Fromy B, Bouye P, Saumet JL, Abraham P, (2002). Current-induced vasodilation during water iontophoresis (5 min, 0.10 mA) is delayed from current onset and involves aspirin sensitive mechanisms. J Vasc Res 39: 59-71.
7. Ferrell WR, Ramsay JE, Brooks N, Lockhart JC, Dickson S, McNeece GM, et al. (2002). Elimination of electrically induced iontophoretic artefacts: implications for non-invasive assessment of peripheral microvascular function. J Vasc Res 39: 447-455.
8. Franks AG, Jr, (1982). Topical glyceryl trinitrate as adjunctive treatment in Raynaud's disease. Lancet 1: 76-77.
9. Fregert S, (1981). Manual of Contact Dermatitis, 2nd edn. Munksgaard: Copenhagen. 71-76.
10. Herrick AL, (2000). Vascular function in systemic sclerosis. Curr Opin Rheumatol 12: 527-533.
11. Kalia YN, Naik A, Garrison J, Guy RH, (2004). Iontophoretic drug delivery. Adv Drug Deliv Rev 56: 619-658.
12. Korn JH, Mayes M, Matucci Cerinic M, Rainisio M, Pope J, Hachulla E, et al. (2004). Digital ulcers in systemic sclerosis: prevention by treatment with bosentan, an oral endothelin receptor antagonist. Arthritis Rheum 50: 3985-3993.
13. Kumar MG, Lin S, (2008). Transdermal iontophoresis: impact on skin integrity as evaluated by various methods. Crit Rev Ther Drug Carrier Syst 25: 381-401.
14. Morimoto Y, Hatanaka T, Sugibayashi K, Omiya H, (1992). Prediction of skin permeability of drugs: comparison of human and hairless rat skin. J Pharm Pharmacol 44: 634-639.
15. Murray AK, Herrick AL, Gorodkin RE, Moore TL, King TA, (2005). Possible therapeutic use of vasodilator iontophoresis. Microvasc Res 69: 89-94.
16. Murray AK, Moore TL, King TA, Herrick AL, (2008). Vasodilator iontophoresis a possible new therapy for digital ischaemia in systemic sclerosis? Rheumatology (Oxford) 47: 76-79.
17. Roustit M, Blaise S, Cracowski JL, (2009). Sodium nitroprusside iontophoresis on the finger pad does not consistently increase skin blood flow in healthy controls and patients with systemic sclerosis. Microvasc Res 77: 260-264.
18. Turner J, Belch JJ, Khan F, (2008). Current concepts in assessment of microvascular endothelial function using laser Doppler imaging and iontophoresis. Trends Cardiovasc Med 18: 109-116.
19. Wigley FM, Seibold JR, Wise RA, McCloskey DA, Dole WP, (1992). Intravenous iloprost treatment of Raynaud's phenomenon and ischemic ulcers secondary to systemic sclerosis. J Rheumatol 19: 1407-1414.